| 25/02/25 | 07:00:10 | 25 Feb 2025 | | Presentation at PharmaSynergyRx Event |
| 24/02/25 | 07:00:08 | 24 Feb 2025 | | Entry into an Arrangement Agreement with Awakn |
| 30/01/25 | 12:00:00 | 30 Jan 2025 | | Proactive Investors interview with Chairman |
| 27/01/25 | 07:00:03 | 27 Jan 2025 | | Update on Awakn Life Sciences’ R&D Progress |
| 24/01/25 | 07:00:07 | 24 Jan 2025 | | Investor Presentation |
| 21/01/25 | 14:29:26 | 21 Jan 2025 | | Proactive Investors interview with CEO |
| 21/01/25 | 07:00:06 | 21 Jan 2025 | | Update on FDA Pre-IND Meeting for Awakn |
| 15/01/25 | 07:00:06 | 15 Jan 2025 | | Interview with CEO |
| 14/01/25 | 07:00:07 | 14 Jan 2025 | | Change of Name to Solvonis Therapeutics plc |
| 06/01/25 | 14:27:38 | 6 Jan 2025 | | Result of General Meeting and change of name |
| 18/12/24 | 07:00:07 | 18 Dec 2024 | | Proactive Investors Interview with CEO and Chair |
| 16/12/24 | 07:00:05 | 16 Dec 2024 | | Proposed acquisition of Awakn Life Sciences Corp |
| 11/12/24 | 07:00:03 | 11 Dec 2024 | | Initial Results University of Nottingham |
| 03/12/24 | 09:44:28 | 3 Dec 2024 | | Notice of GM and proposed name change |
| 15/10/24 | 07:00:04 | 15 Oct 2024 | | Research Agreement |
| 04/10/24 | 07:00:03 | 4 Oct 2024 | | Research and development update |
| 26/09/24 | 12:40:29 | 26 Sept 2024 | | Non Regulatory-Interview with Dennis Purcell |
| 26/09/24 | 07:00:14 | 26 Sept 2024 | | Directorate Change and grant of options |
| 13/09/24 | 07:00:05 | 13 Sept 2024 | | Half-year Report |
| 28/08/24 | 07:00:03 | 28 Aug 2024 | | Commercial Collaboration Progress Update |
| 13/08/24 | 07:00:12 | 13 Aug 2024 | | Holding(s) in Company |
| 12/08/24 | 10:21:09 | 12 Aug 2024 | | Directorate Change |
| 08/08/24 | 10:08:55 | 8 Aug 2024 | | Holding(s) in Company |
| 01/08/24 | 07:00:18 | 1 Aug 2024 | | Directorate Change |
| 31/07/24 | 17:00:01 | 31 Jul 2024 | | Total Voting Rights |
| 30/07/24 | 07:00:15 | 30 Jul 2024 | | Non Regulatory Appnt of Senior Scientific Advisor |
| 23/07/24 | 13:59:21 | 23 Jul 2024 | | Holding(s) in Company |
| 23/07/24 | 07:00:06 | 23 Jul 2024 | | Commercial Collaboration |
| 18/07/24 | 07:00:07 | 18 Jul 2024 | | Commercial Collaboration |
| 17/07/24 | 09:28:11 | 17 Jul 2024 | | Holding(s) in Company |
| 15/07/24 | 07:00:08 | 15 Jul 2024 | | Directorate Change |
| 12/07/24 | 07:00:09 | 12 Jul 2024 | | Holding(s) in Company |
| 12/07/24 | 07:00:09 | 12 Jul 2024 | | Holding(s) in Company |
| 11/07/24 | 09:36:46 | 11 Jul 2024 | | Holding(s) in Company |
| 11/07/24 | 09:27:52 | 11 Jul 2024 | | Holding(s) in Company |
| 11/07/24 | 09:26:41 | 11 Jul 2024 | | Holding(s) in Company |
| 11/07/24 | 09:20:56 | 11 Jul 2024 | | Holding(s) in Company |
| 11/07/24 | 09:20:32 | 11 Jul 2024 | | Holding(s) in Company |
| 11/07/24 | 07:00:08 | 11 Jul 2024 | | Patent Filings |
| 10/07/24 | 16:24:22 | 10 Jul 2024 | | Holding(s) in Company |
| 10/07/24 | 08:10:00 | 10 Jul 2024 | | Admission & Director/PDMR Shareholding |
| 03/07/24 | 14:29:19 | 3 Jul 2024 | | Publication of a Prospectus |
| 28/06/24 | 12:58:54 | 28 Jun 2024 | | Result of AGM |
| 07/06/24 | 07:00:08 | 7 Jun 2024 | | Business Update |
| 04/06/24 | 16:26:23 | 4 Jun 2024 | | Notice of AGM |
| 31/05/24 | 07:00:05 | 31 May 2024 | | Patent Application |
| 28/05/24 | 07:00:15 | 28 May 2024 | | Regulatory Application |
| 09/05/24 | 07:00:08 | 9 May 2024 | | Update on recent developments |
| 07/05/24 | 07:00:12 | 7 May 2024 | | Grant of Haemostatic Hydrogel Patent |
| 03/05/24 | 07:00:09 | 3 May 2024 | | Divestment of Graft Polymer d.o.o – Slo facility |
